On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Gedea Biotech AB's own share of each project, not the project's full budget.
- Horizon Europe€2.5M · 1 project
- Horizon 2020€2.1M · 2 projects
Projects
3 EU-funded projects, newest first. Gedea Biotech AB led 3 of them as coordinator. Each links to the official record.
- pHyphCoordinator
Breakthrough dual-action OTC tablet for treatment and prevention of both bacterial and fungal vaginitis
Horizon Europe · 2024–2026 · Project on CORDIS ↗
€2.5Mtheir share - NEFERTITICoordinator
A Novel Eco-Friendly, dually Efficient and Resistance-free Treatment of vaginITIs
Horizon 2020 · 2020–2022 · Project on CORDIS ↗
€2.0Mtheir share - NEFERTITICoordinator
NEFERTITI: A Novel Eco-Friendly, dually Efficient and Resistance-free Treatment of vaginITIs
Horizon 2020 · 2018–2019 · Project on CORDIS ↗
€50ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Link Medical Research ASNorway · 1 shared project
- Nottingham University Hospitals Nhs TrustUnited Kingdom · 1 shared project
- Link Medical Research LtdUnited Kingdom · 1 shared project
- Link Medical ApSDenmark · 1 shared project
- Link Medical Research ABSweden · 1 shared project
- Link Medical GmbHGermany · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- antibiotic resistance
- antibiotics
- bacteriology
- drug resistance
- mycology
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.